Zhejiang AngLiKang Pharmaceutical CO.,LTD. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 697.88 million compared to CNY 630.7 million a year ago. Revenue was CNY 703.78 million compared to CNY 633.73 million a year ago.

Net income was CNY 79.1 million compared to CNY 65.58 million a year ago. Basic earnings per share from continuing operations was CNY 0.3995 compared to CNY 0.3234 a year ago. Diluted earnings per share from continuing operations was CNY 0.3995 compared to CNY 0.3234 a year ago.